Filter By Industry
Filter By Tag

Newsroom

Citrus Therapeutics Press releases

1 - 2 of 2 Press Releases

Citrus Therapeutics to Present CTZ1™ Groundbreaking Therapy for Age-Related Macular Degeneration (AMD) at Ophthalmology Innovation Summit XII
Nov 21, 2022
Presentation will highlight this novel vascular disruptive antioxidant agent for treating wet and dry AMD with potential synergy given concurrent therapies

Citrus Therapeutics Files U.S. Patent for CTZ1™ Groundbreaking Therapy for Age-Related Macular Degeneration (AMD)
Sep 26, 2022
A novel vascular disruptive antioxidant agent for treating wet and dry AMD with potential synergy given concurrent therapies


Citrus Therapeutics RSS Feed